assessment of novel treatment options for patients with pv
Published 10 years ago • 347 plays • Length 19:03Download video MP4
Download video MP3
Similar videos
-
17:54
current therapy options and clinical outcomes analysis in patients with pv
-
19:41
recent advances in the diagnosis, prognosis and survival predictions of patients with pv
-
17:02
indication for cytoreductive therapy in et and pv: do we have it right?
-
27:23
interactive case: jak inhibitors for the successful management of polycythemia vera
-
19:36
evolution of the assessment of clinical benefit in polycythemia vera
-
20:50
prognosis and outcome of patients with advanced et and pv
-
19:11
novel agents and combination therapies in myelofibrosis
-
16:28
update on long-acting interferons for mpn
-
9:55
take an assessment of your polycythemia vera (pv) symptoms
-
8:09
abdulraheem yacoub, ash 2019: novel agents for the treatment of pv and mf
-
19:23
novel agents and combination therapies in myelofibrosis
-
20:15
hydroxyurea intolerance/resistance in polycythemia vera
-
22:40
treatment goals in essential thrombocythemia and polycythemia vera
-
17:25
case study: inadequately controlled polycythemia vera (pv)
-
25:15
how to manage side effects of jak inhibitors for mylofibrosis in the clinical practice
-
21:11
mf marrow morphology: key takeaways from who 2016 diagnostic update
-
23:38
why mpns transform to aml
-
24:44
evaluation of a novel tool for the study of early metastasis...
-
18:50
jak inhibitors for et and pv: what have we learned so far?